Total Payments
$47,330
2024 Payments
$9,271
Companies
54
Transactions
522
Medicare Patients
14,422
Medicare Billing
$1.6M
Payment Breakdown by Category
Other$29,408 (62.1%)
Food & Beverage$13,226 (27.9%)
Consulting$2,530 (5.3%)
Travel$2,098 (4.4%)
Education$68.45 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,200 | 8 | 40.6% |
| Food and Beverage | $13,226 | 500 | 27.9% |
| Long term medical supply or device loan | $10,208 | 2 | 21.6% |
| Consulting Fee | $2,530 | 1 | 5.3% |
| Travel and Lodging | $2,098 | 7 | 4.4% |
| Education | $68.45 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Penumbra, Inc. | $25,069 | 28 | $0 (2022) |
| AngioDynamics, Inc. | $10,208 | 2 | $0 (2024) |
| ABIOMED | $1,741 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,117 | 65 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $961.54 | 56 | $0 (2024) |
| Amgen Inc. | $861.50 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $860.79 | 50 | $0 (2024) |
| Boston Scientific Corporation | $621.69 | 13 | $0 (2023) |
| Cardiovascular Systems Inc. | $614.26 | 16 | $0 (2022) |
| Abbott Laboratories | $479.02 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,271 | 68 | AngioDynamics, Inc. ($7,500) |
| 2023 | $4,516 | 69 | AngioDynamics, Inc. ($2,708) |
| 2022 | $6,409 | 64 | Penumbra, Inc. ($5,133) |
| 2021 | $1,548 | 70 | AstraZeneca Pharmaceuticals LP ($217.51) |
| 2020 | $6,828 | 59 | Penumbra, Inc. ($5,258) |
| 2019 | $15,451 | 95 | Penumbra, Inc. ($13,556) |
| 2018 | $2,923 | 83 | Penumbra, Inc. ($1,122) |
| 2017 | $383.78 | 14 | ABIOMED ($115.32) |
All Payment Transactions
522 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $7,500.00 | General |
| Category: ET | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.53 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Genetic Disease | ||||||
| 10/16/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: DEVICES | ||||||
| 10/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $25.77 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.33 | General |
| 09/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $101.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $93.30 | General |
| Category: Lithoplasty | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardio-renal | ||||||
| 09/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Genetic Disease | ||||||
| 08/14/2024 | Medtronic, Inc. | FFRANGIO (Device) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Fractional Flow Reserve (FFR) Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 4,637 | 8,023 | $1.6M | $469,846 |
| 2022 | 46 | 3,729 | 5,519 | $1.3M | $411,338 |
| 2021 | 49 | 3,226 | 4,398 | $1.2M | $371,945 |
| 2020 | 39 | 2,830 | 3,858 | $1.1M | $338,950 |
Total Patients
14,422
Total Services
21,798
Medicare Billing
$1.6M
Procedure Codes
187
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 425 | 656 | $137,760 | $60,408 | 43.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 168 | 1,047 | $88,995 | $50,206 | 56.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 172 | 1,057 | $137,410 | $40,317 | 29.3% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 36 | 36 | $97,320 | $38,269 | 39.3% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 16 | 16 | $75,200 | $30,009 | 39.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 179 | 184 | $156,400 | $27,261 | 17.4% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 52 | 104 | $60,840 | $24,373 | 40.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 131 | 133 | $68,495 | $19,152 | 28.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 141 | 422 | $46,420 | $16,126 | 34.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 42 | 42 | $46,200 | $14,124 | 30.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 78 | 312 | $29,640 | $13,117 | 44.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,375 | 1,978 | $224,871 | $12,084 | 5.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 105 | 105 | $28,350 | $12,065 | 42.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 61 | 61 | $29,890 | $8,982 | 30.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 93 | $16,554 | $8,393 | 50.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 59 | $21,240 | $7,573 | 35.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 41 | 82 | $15,580 | $7,255 | 46.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 15 | 16 | $19,520 | $7,037 | 36.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 36 | 37 | $17,205 | $7,032 | 40.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 34 | 34 | $44,200 | $6,343 | 14.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 62 | 62 | $17,435 | $6,172 | 35.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 96 | 96 | $27,840 | $5,120 | 18.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 91 | 91 | $16,380 | $4,837 | 29.5% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 28 | 28 | $26,320 | $4,602 | 17.5% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 148 | 152 | $12,160 | $4,421 | 36.4% |
About Dr. Ryan Melchior, DO
Dr. Ryan Melchior, DO is a Cardiovascular Disease healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1316267511.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Melchior, DO has received a total of $47,330 in payments from pharmaceutical and medical device companies, with $9,271 received in 2024. These payments were reported across 522 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,200).
As a Medicare-enrolled provider, Melchior has provided services to 14,422 Medicare beneficiaries, totaling 21,798 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Midlothian, VA
- Active Since 06/10/2010
- Last Updated 04/29/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1316267511
Products in Payments
- Indigo (Device) $18,802
- Auryon Laser System 100-120 Vac (Device) $10,208
- Indigo System (Device) $5,117
- Impella (Device) $1,741
- Penumbra Ruby Coil (Device) $1,118
- XARELTO (Drug) $860.79
- Repatha (Biological) $754.86
- ENTRESTO (Drug) $643.19
- BRILINTA (Drug) $556.39
- ELIQUIS (Drug) $352.22
- Coronary Orbital Atherectomy System (Device) $334.71
- HawkOne (Device) $328.23
- LEQVIO (Drug) $318.35
- MULTAQ (Drug) $254.85
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $254.22
- FARXIGA (Drug) $198.58
- DRAGONFLY OPSTAR (Device) $166.98
- ENDURANT IIS (Device) $155.27
- ELUVIA (Device) $144.73
- LifeVest (Device) $142.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Midlothian
Omar Shams, Md, MD
Cardiovascular Disease — Payments: $35,175
Cardiovascular Disease $35,175
Dr. Calvin Newton, M.d, M.D
Cardiovascular Disease — Payments: $28,496
Cardiovascular Disease $28,496
Dr. Frederick Schnatz, D.o, D.O
Cardiovascular Disease — Payments: $10,506
Cardiovascular Disease $10,506
Dr. Ramesh Kundur, M.d, M.D
Cardiovascular Disease — Payments: $4,961
Cardiovascular Disease $4,961
Dr. Mark Warner, M.d, M.D
Cardiovascular Disease — Payments: $4,413
Cardiovascular Disease $4,413
Dr. Mark Johns, Md, MD
Cardiovascular Disease — Payments: $1,903
Cardiovascular Disease $1,903